Stock Earnings
CHIEF EXECUTIVE OFFICER Palleiko Benjamin L sale 7,169 shares of KalVista Pharmaceuticals Inc [KALV]
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Menu
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
KalVista Pharmaceuticals Inc’s filing revealed that its CHIEF EXECUTIVE OFFICER Palleiko Benjamin L unloaded Company’s shares for reported $0.1 million
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
KalVista Pharmaceuticals Inc’s recent filing unveils that its CHIEF EXECUTIVE OFFICER Palleiko Benjamin L unloaded Company’s shares for reported $0.1
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
KalVista Pharmaceuticals Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Audhya Paul K. unloaded Company’s shares for reported $24272.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. KalVista Pharmaceuticals
KalVista Pharmaceuticals Inc’s recent filing unveils that its CHIEF MEDICAL OFFICER Audhya Paul K. unloaded Company’s shares for reported $24272.0
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
KalVista Pharmaceuticals Inc’s recent filing unveils that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $0.24